Rho kinase inhibitor fasudil reduces l ‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease-Reference-Cited by-同舟云学术

Rho kinase inhibitor fasudil reduces l ‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease

Published:2020-11-03 Issue:24 Volume:177 Page:5622-5641
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Lopez‐Lopez Andrea¹²^ORCID,Labandeira Carmen M.¹³^ORCID,Labandeira‐Garcia Jose L.¹²^ORCID,Muñoz Ana¹²^ORCID

Affiliation:

1. Laboratory of Cellular and Molecular Neurobiology of Parkinson's Disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Department of Morphological Sciences, IDIS University of Santiago de Compostela Santiago de Compostela Spain

2. Networking Research Center on Neurodegenerative Diseases (CiberNed) Madrid Spain

3. Department of Clinical Neurology, Hospital Alvaro Cunqueiro University Hospital Complex Vigo Spain

Funder

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia

European Regional Development Fund

Instituto de Salud Carlos III

Secretaría de Estado de Investigación, Desarrollo e Innovación

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15275

Reference64 articles.

1. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

2. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

3. ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo

4. Exogenous corticosterone reduces l-DOPA-induced dyskinesia in the hemi-parkinsonian rat: Role for interleukin-1β

5. Control of Synaptic Strength by Glial TNFα

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitactions: vitamins for the brain;Exploration of Neuroprotective Therapy;2024-07-01

2. Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson’s Disease and Aging;Biomedicines;2024-05-13

3. Altered perivascular spaces in subcortical white matter in Parkinson’s disease patients with levodopa-induced dyskinesia;npj Parkinson's Disease;2024-03-28

4. SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants;CNS Drugs;2024-02-28

5. Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD);Frontiers in Aging Neuroscience;2024-02-14